Back to Search
Start Over
Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
- Source :
-
Journal of the American Heart Association [J Am Heart Assoc] 2018 Jan 26; Vol. 7 (3). Date of Electronic Publication: 2018 Jan 26. - Publication Year :
- 2018
-
Abstract
- Background: The reasons for China's high stroke prevalence are not well understood. The cardiovascular risk factor profiles of China and the United States have not been directly compared in nationally representative population samples.<br />Methods and Results: Using data from the CHARLS (China Health and Retirement Longitudinal Study) and the NHANES (US National Health and Nutrition Examination Survey), we compared cardiovascular risk factors from 2011 to 2012 among people aged 45 to 75 years between the 2 countries (China, 12 654 people; United States, 2607 people): blood pressure, cholesterol, body mass index, waist circumference, fasting plasma glucose, hemoglobin A1c, and high-sensitivity C-reactive protein. Compared with the United States, China had a lower prevalence of hypertension but a higher mean blood pressure and a higher proportion of patients with severe hypertension (≥160/100 mm Hg) (10.5% versus 4.5%). China had substantially lower rates of hypertension treatment (46.8% versus 77.9%) and control (20.3% versus 54.7%). Dyslipidemia was less common in China, but lipid levels were not significantly different because dyslipidemia awareness and control rates in China were 3- and 7-fold lower than US rates, respectively. High-sensitivity C-reactive protein, body mass index, and waist circumference were significantly lower in China than in the United States. Clustering of hypertension with other cardiovascular risk factors was more common in China.<br />Conclusions: Hypertension is more common in the United States, but blood pressure levels are higher in China, which may be responsible for China's high stroke prevalence. The low rates of awareness, treatment, and control of hypertension provide an exceptional opportunity for China to reduce risk in its population.<br /> (© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.)
- Subjects :
- Aged
Antihypertensive Agents therapeutic use
Attitude of Health Personnel
Blood Glucose metabolism
Blood Pressure drug effects
Body Mass Index
Cardiovascular Diseases diagnosis
Cardiovascular Diseases prevention & control
China epidemiology
Diabetes Mellitus blood
Diabetes Mellitus epidemiology
Diabetes Mellitus therapy
Dyslipidemias blood
Dyslipidemias diagnosis
Dyslipidemias drug therapy
Female
Health Knowledge, Attitudes, Practice
Humans
Hypertension diagnosis
Hypertension drug therapy
Hypertension physiopathology
Hypolipidemic Agents therapeutic use
Lipids blood
Longitudinal Studies
Male
Middle Aged
Nutrition Surveys
Obesity epidemiology
Obesity physiopathology
Obesity therapy
Practice Patterns, Physicians'
Prevalence
Prognosis
Risk Assessment
Risk Factors
Time Factors
United States epidemiology
Waist Circumference
Cardiovascular Diseases epidemiology
Dyslipidemias epidemiology
Health Status Disparities
Hypertension epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 2047-9980
- Volume :
- 7
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of the American Heart Association
- Publication Type :
- Academic Journal
- Accession number :
- 29374046
- Full Text :
- https://doi.org/10.1161/JAHA.117.007462